caa a22 4500 465752713 CHVBK 20180323111838.0 cr unu---uuuuu 170327e19901201xx s 000 0 eng 10.1007/BF01580024 doi (NATIONALLICENCE)springer-10.1007/BF01580024 Holtgrewe H. Johns Hopkins University School of Medicine Baltimore, MA aut The treatment of benign prostatic hyperplasia: a prospective, randomized clinical trial to be conducted by the American Urological Association [Elektronische Daten] [H. Holtgrewe] Summary: Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male. Springer-Verlag, 1990 World Journal of Urology Springer-Verlag 8/4(1990-12-01), 218-223 0724-4983 8:4<218 1990 8 345 https://doi.org/10.1007/BF01580024 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01580024 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Holtgrewe H. Johns Hopkins University School of Medicine Baltimore, MA aut NATIONALLICENCE 773 0- World Journal of Urology Springer-Verlag 8/4(1990-12-01), 218-223 0724-4983 8:4<218 1990 8 345 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer